CORCEPT THERAPEUTICS INC (CORT) Stock Analyst Ratings
USA - NASDAQ:CORT - US2183521028 - Common Stock
72.52 USD
-0.46 (-0.63%)
73.97 USD
+1.45 (+2%)
ChartMill assigns a Buy % Consensus number of 82% to CORT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 137.96. This target is 90.23% above the current price.
CORT was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CORT.
In the previous month the buy percentage consensus was at a similar level.
CORT was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-31 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-30 | Truist Securities | Maintains | Buy -> Buy |
| 2024-09-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Truist Securities | Maintains | Buy -> Buy |
| 2024-06-04 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-02 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
CORCEPT THERAPEUTICS INC / CORT FAQ
What is the price target for CORT stock?
10 analysts have analysed CORT and the average price target is 137.96 USD. This implies a price increase of 90.23% is expected in the next year compared to the current price of 72.52.
Can you provide the consensus rating for CORCEPT THERAPEUTICS INC stock?
The consensus rating for CORCEPT THERAPEUTICS INC (CORT) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CORCEPT THERAPEUTICS INC (CORT)?
The number of analysts covering CORCEPT THERAPEUTICS INC (CORT) is 10.